Nanotechnology

Abstract Cannabidiol (CBD) exhibits poor oral bioavailability (approximately 6%) due to low solubility and excessive first-pass metabolism, limiting its therapeutic...

Abstract Non-viral nanocarriers are increasingly adopted as safer alternatives to viral vectors for gene delivery, enabling scalability and improved manufacturability....

Abstract Curcumin has been widely reported to exhibit anticancer potential; however, its clinical application is limited by poor aqueous solubility...

Abstract Colorectal cancer (CRC) presents a significant global health challenge, where the efficacy of conventional treatments is often hampered by...

Abstract Cannabidiol (CBD) is a non-psychoactive compound derived from Cannabis sativa. It has attracted significant attention for its anti-inflammatory, pain-relieving, and...

Abstract This study aims to develop the freeze-dried core–shell nanoparticles (nanocapsules; NCs) as an effective dosage form for improving the...

See our next Live Webinar on the topic of: Nano-Formulations: Turning Insoluble APIs into Effective Dosage Forms   Presentation 1:...

Abstract Ulcerative colitis (UC) is a chronic inflammatory bowel disease with no curative therapy. Hesperidin (HDN) exhibits potent anti-inflammatory and...

This poster has been presented at the  15th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology  which took place in...

Abstract Background/Objectives: Meloxicam (MLX) is a nonsteroidal anti-inflammatory drug (NSAID) recommended for treating acute and chronic pain in dogs, frequently...